On March 25, AMCP joined a diverse coalition of pharmacy stakeholders in expressing support for the Equitable Community Access for Pharmacists Services Act. This bill would permanently authorize pharmacists' ability to provide health care services during public health emergencies.
On April 19, AMCP joined a pharmacy stakeholder letter addressed to the Biden administration's COVID-19 czar, Dr. Ashish Jha. The letter urged the Biden administration to allow qualified pharmacists to prescribe oral antivirals to treat COVID-19 and maintain PREP Act services provided by pharmacists.
AMCP Foundation announces Best Poster recipients during AMCP 2022. This semiannual competition culminates twice per year at AMCP national meetings, with awards for new practitioners presented in three categories.
During AMCP Foundation's 2022 National P&T Competition, the University of Michigan received the first place prize. The competition convened student pharmacists from around the country to develop a formulary drug monograph, considering evidence gaps; value; health equity; and utilization management tools.
Mason Johnson, BS, PharmD candidate, will serve as the 2022–2023 Executive Fellow in Health Care Association Leadership. His fellowship will begin July 1, 2022.
AMCP applauds Senators Moore Capito (R-WV) and Shaheen (D-NH) and Congressmen Thompson (D-CA-5) and McKinley (R-WV-1) on the introduction of the bipartisan Access to Prescription Digital Therapeutics Act.
On March 18, AMCP provided comments to the HHS Office of the National Coordinator for Health Information Technology regarding electronic prior authorization.
On March 9, AMCP joined 13 pharmacy organizations in urging President Biden to authorize pharmacists to order and administer oral antivirals to treat COVID-19 as part of the administration's Test to Treat policy.